SC 13G/A | 2015-02-09 | BlackRock Inc. | ALEXION PHARMACEUTICALS INC | 13,455,313 | 6.8% | EDGAR |
SC 13G/A | 2014-12-10 | PRICE T ROWE ASSOCIATES INC /MD/ | ALEXION PHARMACEUTICALS INC | 19,846,690 | 10.0% | EDGAR |
SC 13G/A | 2014-02-14 | FMR LLC | ALEXION PHARMACEUTICALS INC | 19,709,437 | 10.1% | EDGAR |
SC 13G/A | 2014-02-13 | Capital Research Global Investors | ALEXION PHARMACEUTICALS INC | 23,703,112 | 12.1% | EDGAR |
SC 13G/A | 2014-02-07 | PRICE T ROWE ASSOCIATES INC /MD/ | ALEXION PHARMACEUTICALS INC | 14,887,308 | 7.5% | EDGAR |
SC 13G/A | 2014-02-07 | PRUDENTIAL FINANCIAL INC | ALEXION PHARMACEUTICALS INC | - | - | EDGAR |
SC 13G/A | 2014-02-07 | WESTFIELD CAPITAL MANAGEMENT CO LP | ALEXION PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
SC 13G/A | 2014-02-06 | JENNISON ASSOCIATES LLC | ALEXION PHARMACEUTICALS INC | 8,397,889 | 4.3% | EDGAR |
SC 13G/A | 2014-01-28 | BlackRock Inc. | ALEXION PHARMACEUTICALS INC | 12,157,603 | 6.2% | EDGAR |
SC 13G/A | 2013-03-08 | Capital Research Global Investors | ALEXION PHARMACEUTICALS INC | 21,006,846 | 10.8% | EDGAR |
SC 13G/A | 2013-02-14 | FMR LLC | ALEXION PHARMACEUTICALS INC | 14,952,509 | 7.7% | EDGAR |
SC 13G | 2013-02-13 | PRUDENTIAL FINANCIAL INC | ALEXION PHARMACEUTICALS INC | 10,417,095 | 5.4% | EDGAR |
SC 13G/A | 2013-02-12 | Capital Research Global Investors | ALEXION PHARMACEUTICALS INC | 18,462,600 | 9.5% | EDGAR |
SC 13G | 2013-02-11 | JENNISON ASSOCIATES LLC | ALEXION PHARMACEUTICALS INC | 10,056,686 | 5.2% | EDGAR |
SC 13G/A | 2013-02-08 | PRICE T ROWE ASSOCIATES INC /MD/ | ALEXION PHARMACEUTICALS INC | 18,500,374 | 9.5% | EDGAR |
SC 13G/A | 2013-02-06 | BlackRock Inc. | ALEXION PHARMACEUTICALS INC | 13,308,771 | 6.8% | EDGAR |
SC 13G/A | 2012-02-14 | FMR LLC | ALEXION PHARMACEUTICALS INC | 21,273,525 | 11.5% | EDGAR |
SC 13G/A | 2012-02-14 | Capital Research Global Investors | ALEXION PHARMACEUTICALS INC | 13,328,122 | 7.2% | EDGAR |
SC 13G/A | 2012-02-13 | PRICE T ROWE ASSOCIATES INC /MD/ | ALEXION PHARMACEUTICALS INC | 14,488,395 | 7.8% | EDGAR |
SC 13G/A | 2012-02-13 | Invus Public Equities, LP | ALEXION PHARMACEUTICALS INC | 1,500,000 | 4.0% | EDGAR |